Iterative Health develops technology that can benefit patients anywhere, regardless of socioeconomic or geographic barriers.
Iterative Health has raised $77.0M in total funding. The most recent round was Series C. The last funding was announced in April 2026.
Iterative Health's investors include Plug and Play, Alumni Ventures, Eli Lilly, Insight Partners, Clearlake Capital Group.
Iterative Health is headquartered in Cambridge, United States.
Iterative Health develops technology that can benefit patients anywhere, regardless of socioeconomic or geographic barriers.
Iterative Health is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Iterative Health — Funding & Investors." VCBacked, April 30, 2026, https://www.vcbacked.co/company/iterative-health. Accessed October 17, 2026.
VCBacked. (2026). Iterative Health — Funding & Investors. Retrieved October 17, 2026, from https://www.vcbacked.co/company/iterative-health
{{cite web |title=Iterative Health — Funding & Investors |url=https://www.vcbacked.co/company/iterative-health |website=VCBacked |access-date=October 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated